An Antiviral Formulation with RNA Dependent RNA Polymerase and Viral DNA Gyrase Suppressive Features for The Treatment of Coronaviral & Adenoviral Infections (NOVIR ) NOVIR Par Mas Pharmaceuticals An Antiviral Formulation Consisting of 3 Protopanaxatriol-Class Glucopyranoside Analouges , A Semi-Synthetic Flavonol Glycoside Derivative and an Immuno-Modulatory Ginsenoside RG3 Subvariant for The Treatment of Coronaviral & Adenoviral Infections via Suppressing DNA Polymerase, RNA Dependent RNA… Créé le 21 avril 2020. Mis à jour le 1 septembre 2021 — Creative Commons Attribution 4.0 0 réutilisation 0 favori
